GlassScriptPhysician profile
Robert T Derosa
NPI 1154320885
$1,733.20
in general payments reported to CMS, 2019-2025
21 companies · $391 in 2025
The $391 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $192 · 2020: $12.67 · 2022: $244 · 2023: $385 · 2024: $509 · 2025: $391.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,285.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,284.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $334.14 | 2023-2025 | Veozah |
| Organon LLC | $313.88 | 2022-2025 | Nexplanon |
| Sage Therapeutics, LLC | $164.60 | 2024-2025 | Zurzuvae |
| Hologic Sales and Service, LLC | $108.33 | 2019-2023 | Myosure Tissue Removal Device, Acessa Provu System, Fluent Fluid Management System |
| Pfizer INC. | $98.69 | 2020-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $98.00 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $84.90 | 2024 | Myfembree |
| Gynesonics, INC. | $81.69 | 2022 | |
| Abbvie INC. | $66.44 | 2019 | |
| Exeltis, USA INC. | $61.65 | 2023-2025 | Slynd |
| Daiichi Sankyo INC. | $59.19 | 2022-2024 | Injectafer |
| Myriad Women'S Health, INC. | $51.86 | 2023 | Myrisk |
| Roche Diagnostics Corporation | $50.33 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $28.02 | 2025 | Exparel |
| Therapeuticsmd, INC. | $27.29 | 2019-2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $23.70 | 2025 | |
| Mayne Pharma Commercial LLC | $18.42 | 2022 | |
| Coopersurgical, INC. | $18.28 | 2025 | Paragard T 380a |
| Smith+Nephew, INC. | $16.66 | 2025 | Pico 7 |
| Optumhealth Care Solutions, LLC | $16.01 | 2024 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Merck Sharp & Dohme LLC | $11.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Derosa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.